Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Johnson & Johnson Pharmaceutical Research & Development
Scientific Title
A phase I study investigating the safety and tolerability of an infusion of T lymphocytes transduced with an anti-Lewis Y (LeY) chimeric receptor gene in patients with LeY expressing solid tumours